Crispr Therapeutics shares tumble after significant earnings miss
In a remarkable display of market confidence, shares of Crane Co. (CR) have surged to an all-time high, reaching a price level of $188.62. With a market capitalization of $10.8 billion and a P/E ratio of 35.8x, InvestingPro analysis suggests the stock is trading above its Fair Value. This milestone underscores a period of significant growth for the diversified manufacturer, which has seen its stock value climb by an impressive 30.87% over the past year, supported by strong revenue growth of 17.2%. Investors have rallied behind Crane’s robust financial performance and strategic initiatives, propelling the stock to new heights. However, InvestingPro data indicates the stock’s RSI is in overbought territory, suggesting caution may be warranted. The company’s ascent to this record price level reflects a strong vote of confidence from the market, suggesting a positive trajectory for Crane Co.’s future. Discover deeper insights and 15 additional exclusive ProTips for CR with InvestingPro, including comprehensive valuation analysis and future growth projections.
In other recent news, Crane Co. reported a strong first quarter in 2025, with earnings per share (EPS) surpassing expectations at $1.39, compared to the forecasted $1.27. The company achieved a 7.5% increase in core sales, driven by its Aerospace & Electronics segment, although revenue slightly missed projections at $557.6 million against a forecast of $564 million. This performance was bolstered by a 12% rise in the company’s backlog, reaching a record $1.35 billion. Crane’s financial position remains solid, with $188 million in net cash, supporting potential mergers and acquisitions.
Crane’s strategic move to acquire Precision Sensors & Instrumentation (PSI) for $1.06 billion is expected to enhance its sensor technology offerings. Stifel analysts raised their price target for Crane to $165, maintaining a Hold rating, reflecting cautious optimism about the acquisition’s impact. Meanwhile, DA Davidson reaffirmed a Buy rating and a $200 price target, citing Crane’s execution and growth potential in high-potential markets. The company’s disciplined approach to mergers and acquisitions is supported by its strong balance sheet, positioning it well for future strategic growth opportunities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.